BioNano Genomics, Inc. WT EXP 082123 (BNGOW)

Growth

Revenue 5Y-
Revenue 3Y-
EPS 5Y-
EPS 3Y-
Dividend 5Y-
Dividend 3Y-

Capital Efficiency

ROIC-42.37%
ROE-47.94%
ROA-44.98%
ROTA-48.35%

Capital Structure

Market Cap15.41B
EV15.39B
Cash28.17M
Current Ratio6.51
Debt/Equity0.13
Net Debt/EBITDA0.13
Show More

Income Statement

Select a metric from the list below to chart it

Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
TTM
Income Statement
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
TTM
Revenue
6.8
9.5
12.0
10.1
8.5
18.0
30.7
Revenue % Chg.
-
39.9%
26.3%
-15.6%
-16.1%
111.5%
125.4%
Cost of Revenue
3.6
6.0
8.7
6.8
5.7
14.1
24.6
Cost of Revenue % Chg.
-
68.5%
44.5%
-22.3%
-15.3%
146.2%
159.9%
Gross Profit
3.2
3.5
3.3
3.4
2.8
3.9
6.1
Gross Profit % Chg.
-
8.1%
-5.3%
2.2%
-17.5%
39.7%
47.0%
Gross Profit Margin
47.3%
36.6%
27.4%
33.2%
32.6%
21.5%
19.9%
Gross Profit Margin % Chg.
-
-22.7%
-25.0%
21.1%
-1.7%
-33.9%
-34.8%
R&D Expenses
11.4
12.0
9.5
9.1
10.3
22.5
48.7
R&D Expenses % Chg.
-
5.0%
-21.0%
-4.3%
12.9%
119.2%
245.8%
Selling, General, & Admin Expenses
-
-
-
-
-
58.5
97.8
Selling, General, & Admin Expenses % Chg.
-
-
-
-
-
-
149.0%
Other Expenses
13.0
14.1
14.2
20.2
31.1
-
-
Other Expenses % Chg.
-
8.7%
1.0%
41.7%
54.1%
-
-
Operating Income
-21.2
-23.2
-20.4
-25.9
-38.6
-77.1
-123.0
Operating Income % Chg.
-
9.7%
12.1%
26.7%
49.0%
100.0%
149.9%
Operating Income Margin
-311.6%
-244.3%
-170.1%
-255.4%
-453.4%
-428.8%
-400.3%
Operating Income Margin % Chg.
-
21.6%
30.4%
50.2%
77.5%
5.4%
10.9%
Total Other Income/Expenses Net
2.3
-0.1
1.9
-3.9
-2.5
-1.1
-
Total Other Income/Expenses Net % Chg.
-
-
-
-
35.6%
58.4%
-
Income Before Tax
-18.8
-23.3
-18.5
-29.8
-41.1
-78.2
-151.3
Income Before Tax % Chg.
-
23.9%
20.8%
61.2%
37.9%
90.3%
196.0%
Income Before Tax Margin
-277.3%
-245.6%
-154.0%
-294.1%
-483.1%
-434.6%
-492.5%
Income Before Tax Margin % Chg.
-
11.4%
37.3%
91.0%
64.2%
10.0%
31.3%
Income Tax Expense
0.0
0.0
0.0
0.0
0.0
5.7
5.8
Income Tax Expense % Chg.
-
43.5%
-16.4%
35.7%
38.7%
19483.5%
9223.0%
Net Income
-18.8
-23.4
-18.5
-29.8
-41.1
-72.4
-145.6
Net Income % Chg.
-
24.0%
20.8%
61.2%
37.9%
76.2%
184.5%
Net Income Margin
-277.5%
-245.8%
-154.1%
-294.3%
-483.4%
-402.8%
-474.0%
Net Income Margin % Chg.
-
11.4%
37.3%
91.0%
64.2%
16.7%
26.2%
Weighted Avg. Shares Out
-
-
-
-
-
-
286.1
EPS
-
-
-
-
-
-
-0.2
Weighted Avg. Shares Out Dil
-
-
-
-
-
-
286.1
EPS Diluted
-
-
-
-
-
-
-0.2
Interest Income
-
-
-
-
-
0.2
1.0
Interest Expense
0.5
0.6
1.4
2.3
2.5
-0.9
-0.7
Interest Expense % Chg.
-
25.7%
133.7%
65.5%
10.2%
-
-
EBIT
-19.3
-23.9
-19.9
-32.1
-43.6
-77.0
-149.6
EBIT % Chg.
-
24.0%
17.0%
61.5%
35.9%
76.6%
192.7%
EBIT Margin
-284.2%
-251.8%
-165.5%
-316.7%
-512.7%
-428.2%
-487.0%
EBIT Margin % Chg.
-
11.4%
34.3%
91.4%
61.9%
16.5%
29.9%
Depreciation & Amortization
1.1
1.5
1.3
1.1
1.5
3.4
8.9
Depreciation & Amortization % Chg.
-
34.9%
-12.2%
-14.6%
31.2%
126.5%
412.9%
EBITDA
-18.2
-22.4
-18.5
-31.0
-42.1
-73.6
-140.7
EBITDA % Chg.
-
23.3%
17.4%
66.9%
36.1%
74.8%
185.0%
EBITDA Margin
-267.8%
-236.0%
-154.5%
-305.6%
-495.3%
-409.5%
-458.2%
EBITDA Margin % Chg.
-
11.9%
34.5%
97.8%
62.1%
17.3%
26.5%